farnesol has been researched along with Mesothelioma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hiroshima, K; Jiang, Y; Kawamura, K; Kobayashi, H; Okamoto, S; Sekine, I; Shimada, H; Shingyoji, M; Tada, Y; Tagawa, M; Takiguchi, Y; Tatsumi, K | 1 |
Bitterman, P; Greatens, T; Kratzke, RA; Polunovsky, VA; Rubins, JB; Tan, AT | 1 |
2 other study(ies) available for farnesol and Mesothelioma
Article | Year |
---|---|
Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions.
Topics: Apoptosis; cdc42 GTP-Binding Protein; Cell Line, Tumor; Diphosphonates; Diterpenes; DNA Topoisomerases, Type II; Farnesol; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Leucine; Mesothelioma; Myeloid Cell Leukemia Sequence 1 Protein; Protein Prenylation; rab GTP-Binding Proteins; rac1 GTP-Binding Protein; rhoA GTP-Binding Protein; RNA, Small Interfering; S Phase; Signal Transduction; Transferases; Zoledronic Acid | 2014 |
Lovastatin induces apoptosis in malignant mesothelioma cells.
Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line; Cell Membrane; Cell Survival; Cytosol; DNA, Neoplasm; Dose-Response Relationship, Drug; Farnesol; Fibroblasts; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mesothelioma; Mevalonic Acid; Protein Prenylation; ras Proteins; Tumor Cells, Cultured | 1998 |